ADMA Biologics, Inc.

Healthcare · Biotechnology · United States

Last price 11.41 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.56B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal anti...